课题基金 / 基金详情

A follow-up study to assess prognostic factors for subjects with positive anti-HCV antibody.

A follow-up study to assess prognostic factors for subjects with positive anti-HCV antibody.
一项评估抗 HCV 抗体阳性受试者预后因素的后续研究。
批准号:
08670437
负责人:
MORI Mitsuru
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

MORI Mitsuru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Purpose : We followed-up inhabitants in the area of high incidence of hepatocellular carcinoma (HCC) to assess their prognostic risk factors with special reference to anti-hepatitis C virus antibody (HCV) seropositivity.Methods : In June of 1992, a baseline survey, including HCV seropositivity, other serological tests, and several life-styles, was conducted for 3,575 inhabitants aged 30 years or over (1,150 males and 2,425 females) at K.Town of Saga Prefecture, where the age-adjusted incidence of HCC was reported as high as 47.2 and 10.2 per 10^5 population in 1987 for males and females ; respectively. A follow-up survey was performed from April to June of 1997.Hazard ratios (HRs) and their 95% confidence intervals of potential risk factors for mortality by all causes as well as for having newly diagnosed HCC were estimated with the Cox's proportional hazard model.Results : During the follow-up period, 73 males and 51 females died with various causes, and 12 males and 10 females were n … More ewly diagnosed as having HCC.The risk on mortality was significantly increased with age (trend, HR=2.76,2.28-3.35) and sex (male, HR=2.18,1.52-3.13). For males, the age-adjusted risks on mortality were Significantly increased with having HCC (HR=13.37,6.83-26.17), any other cancer (HR=5.80,3.56-9.46), liver cirrhosis (HR=8.07,4.23-15.37), HCV seropositivity (HR=2.38,1.42-3.99), and so on. For females, the age-adjusted risks on mortality were significantly increased with having any cancer other than HCC (HR=18.11,10.40-31.53), liver cirrhosis (HR=5.31,2.11-13.39), family history of liver diseases (HR=2.72,1.36-5.47), and so forth. For males, the age-adjusted risks on having HCC were significantly increased with HCV seropositivity (HR=74.56,9.60-579.32), cessation of alcoholic drinking (HR=4.82,1.27-18.24), family history of liver diseases (HR=3.83,1.03-14.23), and so on. For females, the age-adjusted risks on having HCC were significantly increased with HCV seropositivity (HR=29.09,5.60-151.09), cessation of alcoholic drinking (HR=24.22.3.06-191.66), and so forth. Less
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A case-control study on breast cancer with special reference to equol productivity and intestinal bacteria NATTS.
  • 批准号:
    24659325
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.5万
  • 财政年份:
    2012
  • 负责人:
    MORI Mitsuru
  • 依托单位:
Assessment of risk factors for ovarian cancer including serum equol concentration by histopathology with a case-control study
  • 批准号:
    22390135
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.82万
  • 财政年份:
    2010
  • 负责人:
    MORI Mitsuru
  • 依托单位:
The study on risk factors for prostate cancer according to production of equol, a metabolite of isoflavone.
  • 批准号:
    19390176
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $8.74万
  • 财政年份:
    2007
  • 负责人:
    MORI Mitsuru
  • 依托单位:
Life-style related risk factors for ovarian and endometrial cancer in a case-control study
  • 批准号:
    16590505
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2004
  • 负责人:
    MORI Mitsuru
  • 依托单位:
海外基金